Trends in Cardiovascular Medicine
Volume 16, Issue 8 , Pages 292-298, November 2006

Cardiovascular Polycystins: Insights From Autosomal Dominant Polycystic Kidney Disease and Transgenic Animal Models

Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Valbonne, France

Center for Human and Clinical Genetics, Leiden University Medical Center, Postzone S-04-PP.O. Box 9600, 2300 RC Leiden, The Netherlands

Faculté de Médecine, IFR Jean Roche, Laboratoire de Neurophysiologie Cellulaire, 13916 Marseille Cedex 20, France

Mutations in the PKD1 and PKD2 polycystin genes are responsible for autosomal dominant polycystic kidney disease (ADPKD), one of the most prevalent genetic kidney disorders. ADPKD is a multisystem disease characterized by the formation of numerous fluid-filled cysts in the kidneys, the pancreas, and the liver. Moreover, major cardiovascular manifestations are common complications in ADPKD. Intracranial aneurysms and arterial hypertension are among the leading causes of mortality in this disease. In the present review, we summarize our current understanding of the role of polycystins in the development, maintenance, and function of the cardiovascular system.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(06)00114-9

doi:10.1016/j.tcm.2006.07.002

Trends in Cardiovascular Medicine
Volume 16, Issue 8 , Pages 292-298, November 2006